Daniel J. Lippis, the Corporate Vice President for JAPAC at Edwards Lifesciences Corp (NYSE:EW), has disclosed recent stock ...
This was the stock's fourth consecutive day of losses.
Citi analyst Joanne Wuensch maintained a Buy rating on Edwards Lifesciences (EW – Research Report) today. The company’s shares closed yesterday ...
Edwards Lifesciences Corp. engages in the patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into three areas: Transcatheter Heart ...
Edwards Lifesciences Corp. closed $22.48 below its 52-week high ($96.12), which the company reached on March 28th.
Zacks Research raised their FY2024 earnings per share (EPS) estimates for Edwards Lifesciences in a research note issued on ...
Edwards Lifesciences Corp (EW) stock saw a decline, ending the day at $71.09 which represents a decrease of $-2.33 or -3.17% from the prior close of $73.42. The stock opened at $70.54 and touched a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback